Global Celiac Disease Treatment Market Size, Outlook to 2027, By Product, Therapeutic Area, Indication, Approach and Region

 

Global Celiac Disease Treatment Market Research Report: By Treatment, By End-User (Hospitals and clinics, Clinical Research Organizations, Research & Academic Institutes) – Forecast to 2027

Market Highlights

According to MRFR analysis, Celiac Disease Treatment Market is expected to register a CAGR of 18.60% during the forecast period of 2019 to 2025.

Celiac disease is a digestive disorder hindering the functioning of the small intestine. Celiac disease is triggered by eating foods containing gluten and is common among patients of down syndrome, Turner syndrome, and type 1 diabetes.

Rising diabetes cases, increasing prevalence of the celiac disease, favorable government policies across the Western world (the Americas and Europe), increasing number of clinical trials, raising awareness for the disease, and increasing penetration of therapeutic products in the developing economies are some of the major drivers for the global celiac disease treatment market.

However, factors such as limited availability of the treatment options and underdiagnosis/misdiagnosis of celiac disease are projected to restrain the market growth during the forecast period of 2019 to 2025.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8474

Several market players currently dominate the global celiac disease treatment market. The key players are involved in product launches and strategic collaborations to strengthen their market positions.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas are expected to be the largest market owing to the increasing prevalence of celiac disease and rising per capita healthcare expenditure. On a regional basis, America's celiac disease treatment market has been further segmented into North America and Latin America. The North American market is further divided into the US and Canada. The European celiac disease treatment market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The celiac disease treatment market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Increasing patient pool for diabetes and celiac disease, rapidly developing healthcare sector, and rising per capita healthcare sector enables the Asia-Pacific region to be the fastest-growing regional market for celiac treatment during the forecast period. The celiac disease treatment market in the Middle East & Africa has been divided into the Middle East and Africa.

Segmentation

The global celiac disease treatment market has been segmented based on treatment and end-user.

The market, based on treatment, has been divided into a gluten-free diet, vitamin & mineral supplements, enzyme supplement therapy, and medications. The gluten-free diet segment has been further segmented into gluten-free bakery products, gluten-free baby food, gluten-free pasta, and gluten-free meals. The medication segment is further divided into azathioprine and budesonide. The gluten-free diet segment held the largest market share in the market in 2018.

Based on end-user, the celiac disease treatment has been divided into hospitals & clinics, clinical research organizations, and research & academic institutes. Hospitals and clinics were the largest revenue shareholder in the global celiac disease treatment market.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/celiac-disease-treatment-market-8474

Key Players

Some of the key players in the global celiac disease treatment market are Amgen Inc. (US), Amneal Pharmaceuticals LLC (US), BioLineRx (Israel), Calypso Biotech SA (Switzerland), Freedom Foods Group Limited (Australia), General Mills, Inc. (US), Glenmark Pharmaceuticals Inc. (India), Hain Celestial Group, Inc. (US), Innovate Biopharmaceuticals Inc. (US), Kellogg Company (US), Mondelez International Inc. (US), Mylan Pharmaceuticals Inc. (US), Pinnacle Foods, Inc. (US), Selecta Biosciences, Inc (US), Takeda Pharmaceutical Company Ltd (Japan), The Kraft Heinz Company (US), West-Ward Pharmaceutical (US), Zedira GmbH (Germany), Zydus Pharmaceuticals Inc. (US), and others.

You may also be interested in...  

Tumor Necrosis Factor Alpha Inhibitors Market Research Report Global Forecast Till 2027

Autoimmune Disease Treatment Market Research Information Global Forecast Till 2027

Global Blue Biotechnology market Forecast Till 2027

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact:

Akash Anand

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

Comments

Post a Comment

Popular posts from this blog

Rising Prevalence of Cancer to Strengthen the Growth of the Medical Marijuana Market

Image
  MRFR’s Detailed Study Provides Monitoring Medical Marijuana Market by Scope, Applications, Products, Key Players, Emerging Trends, Sales, Revenue, And Market Share and Growth Rate. Covering North America, Europe, Asia Pacific, Middle East and Africa. Over the last decade or so, marijuana has been a key research subject for medical scientists, academicians, and researchers across the globe. The research centers on understanding the various therapeutics benefits that marijuana offers. There have been positive steps taken by law enforcement agencies and healthcare facilities to legalize the production and the sale of marijuana for medical requirements. Medical marijuana refers to the use of cannabis specifically for treating certain health conditions. It boasts the ability to increase the appetites of cancer patients that are undergoing chemotherapy sessions, it strikingly reduces pain relief, and also has other ailments to its name as well. The medical marijuana consists of a chemical
Read more

Syringe and Needle Market Analysis, Industry Growth, Technology Advancement, Swot Analysis and Regional Forecast

Image
Global Syringe and Needle Market Research Report: By Type (Blood Collection Syringe and Needles, Ophthalmic Syringe and Needles, Bone Marrow Syringe and Needles, Catheter Syringe and Needles, and Others), Application (General Surgery, Diagnostic, Respiratory, Orthopedics, Cardiovascular, Dental, and others), Usability (Disposable, Reusable,), End User (Hospital & Clinics, Diagnostic Centers, Home Care, and Others), and Region (Americas, Europe, Asia-Pacific, and Middle East and Africa)—Global Forecast till 2027 Syringes and needles are sterile devices which are used to inject a solution into the body for the treatment. These devices are also used to isolate various types of body fluids, such as tissues from swollen joints and blood from veins. These devices are made up of plastic and glasses with cylinder shaped with a plunger. Now a days there are the huge demands for plastic syringes and needles which is also known as disposal syringes owing to increase in prevalence of infection
Read more

Morphine Market Report 2020: Technological Advancements and Increasing Demand

Image
  Global Morphine Market: By Dosage Form (Injection, Oral), By Application (Pain Management, Diarrhea Suppressant, Cold &Cough Suppressant), By End User (Hospitals& Clinics, Ambulatory Surgical Centers), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region (North America, Europe, Asia-Pacific, Rest of the World)—Forecast to 2027 Medical Morphine Market-Overview The alarming rise in pain-related discomfort cases triggered by the onset of serious ailments is likely to spur the  medical morphine market  in 2020. The pharmaceuticals reports are made by Market Research Future, which includes market options for development. A 7.5% CAGR is estimated to induce the market in the upcoming period. The spike in the prescription of painkillers is anticipated to create an increased scope for the medical morphine market share in the upcoming period. Also, the development of effective drug combinations is estimated to prompt the development of the med
Read more